Nod2: a key regulator linking microbiota to intestinal mucosal immunity

被引:53
|
作者
Biswas, Amlan [1 ,2 ]
Petnicki-Ocwieja, Tanja [1 ,2 ]
Kobayashi, Koichi S. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02215 USA
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2012年 / 90卷 / 01期
关键词
NLR proteins; Nod2; Commensal microflora; Crohn's disease; Paneth cells; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; EPITHELIAL-CELLS; PYRIN DOMAIN; PANETH CELLS; MAINTAIN HOMEOSTASIS; FRAMESHIFT MUTATION; DEFENSIN EXPRESSION; FECAL MICROBIOTA; DENDRITIC CELLS;
D O I
10.1007/s00109-011-0802-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The human intestine harbors a large number of bacteria that are constantly interacting with the intestinal immune system, eliciting non-pathological basal level immune responses. Increasing evidence points to dysbiosis of microbiota in the intestine as an underlying factor in inflammatory bowel disease susceptibility. Loss-of-function mutations in NOD2 are among the stronger genetic factors linked to ileal Crohn's disease. Indeed, Nod2 is a key regulator of microbiota in the intestine, as microflora in the terminal ileum is dysregulated in Nod2-deficient mice. Nod2 is highly expressed in Paneth cells, which are responsible for the regulation of ileal microflora by antimicrobial compounds, and Nod2-deficient ileal intestinal epithelia are unable to kill bacteria efficiently. It is therefore likely that NOD2 mutations in Crohn's disease may increase disease susceptibility by altering interactions between ileal microbiota and mucosal immunity.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 50 条
  • [31] Nod1 and Nod2 in innate immunity and human inflammatory disorders
    Le Bourhis, L.
    Benko, S.
    Girardin, S. E.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1479 - 1484
  • [32] Nod2 in normal and abnormal intestinal immune function
    Abreu, MT
    [J]. GASTROENTEROLOGY, 2005, 129 (04) : 1302 - 1304
  • [33] NOD2 acts as a master regulator of regeneration pathways in the thymus
    Kinsella, Sinead
    Cooper, Kirsten
    deRoos, Paul
    Iovino, Lorenzo
    Jain, Reema
    Dudakov, Jarrod A.
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [34] The Microbiota Protects Against Ischemia/Reperfusion- Induced Intestinal Injury Through NOD2 Signaling
    Perez-Chanona, Ernesto
    Muehlbauer, Marcus
    Jobin, Christian
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S700 - S701
  • [35] The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease
    Liu, Ziyue
    Zhang, Yaqin
    Jin, Tao
    Yi, Chengxue
    Ocansey, Dickson Kofi Wiredu
    Mao, Fei
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [36] Implication of NOD2 Polymorphisms in Intestinal Transplantation Recipients
    Lasa-Lazaro, M.
    Ramos, E.
    Papa-Gobbi, R.
    Hernandez, F.
    Loinaz, C.
    Calvo, J.
    Morales, P.
    Paz-Artal, E.
    Talayero, P.
    [J]. TRANSPLANTATION, 2021, 105 (7S) : S48 - S48
  • [37] NOD2 Acts As a Master Regulator of Endogenous Thymic Regeneration
    Kinsella, Sinead
    Cooper, Kirsten
    DeRoos, Paul
    Jain, Reema
    Iovino, Lorenzo
    Dudakov, Jarrod A.
    [J]. BLOOD, 2018, 132
  • [38] The intermediate filament protein, vimentin, is a regulator of NOD2 activity
    Stevens, Craig
    Henderson, Paul
    Nimmo, Elaine R.
    Soares, Dinesh C.
    Dogan, Belgin
    Simpson, Kenneth W.
    Barrett, Jeffrey C.
    Wilson, David C.
    Satsangi, Jack
    [J]. GUT, 2013, 62 (05) : 695 - 707
  • [39] Intestinal epithelial cells and innate immunity in the intestine: Is CARD15/Nod2 another player?
    Jobin, C
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : 1145 - 1149
  • [40] NOD2 prevents emergence of disease-predisposing microbiota
    Secher, Thomas
    Normand, Sylvain
    Chamaillard, Mathias
    [J]. GUT MICROBES, 2013, 4 (04) : 353 - 356